The nation of Zimbabwe has rejected a substantial American healthcare agreement worth $367m (272 million pounds) over five years over Washington's demand for sensitive data.
This rejection came to light following a government memo from December was disclosed, which showed President Emmerson Mnangagwa deemed the agreement was "unbalanced".
A government spokesperson later stated that the US was demanding access to health data for scientific study and profit while refused to share the resulting advantages from any future vaccines.
"We will now turn to the difficult and regrettable task of scaling back our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the United States had provided more than $1.9bn as health assistance to Zimbabwe during the past two decades.
A medical body in Zimbabwe has appealed for further negotiations to find a deal acceptable to all parties so the country's vital HIV programme can proceed.
Wider Background
This rejection comes after a comparable case in neighbouring Kenya, where a court halted a similar deal with the US following concerns were raised about the safety of Kenyans' health data.
After resuming office recently, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).
The agency had overseen assistance for the American government, but Trump claimed its expenditure was "inefficient" and his government was pursuing direct bilateral agreements to enhance openness and accountability.
According to reports, Sixteen nations in Africa have to date agreed to these new agreements, representing over $18.3bn of fresh investment.
Details of the Declined Deal
The funds for Zimbabwe was intended to gone towards "combating HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".
"It is our view this cooperation could have provided significant advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children presently receiving antiretroviral therapy via American-funded initiatives," the Ambassador said.
However, official spokesman Nick Mangwana argued the arrangement was "asymmetrical".
"The proposal required Zimbabwe to share its biological resources and data over an extended period, without any equivalent guarantee of access to any medical innovations – such as vaccines, diagnostics, or treatments – that could be developed from that provided information," he stated.
"In essence, our country would provide the raw materials for medical research with no assurance that the resulting innovations would be available to our citizens should a future disease outbreak arise."
National Interest and Global Health
He also said that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral health agreements were undermining structures already set up through the global health agency.
The spokesperson gave as an example its Pandemic Benefit-Sharing system designed to deal with future global health emergencies.
"This mechanism is intended to guarantee that when a nation provides its information, the resulting advantages – such as vaccines and treatments – are distributed fairly, not commercialised solely by those with the funds to create them."
These objections regarding the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.
"We welcome continued dialogue with our US partners on how future collaboration might be designed in a manner that respects the sovereignty and dignity of both nations."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the official position, but recommended that negotiations should continue considering a large portion of the nation's HIV programmes depended on international support.
"In cases where technical issues exist, such as those involving data governance or implementation frameworks, these can frequently be addressed through detailed discussion and mutually agreed protections," the group said.
The situation underscores the complex challenges between receiving vital international aid and safeguarding local interests in an ever more interconnected world.